We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

DYMIND BIOTECHNOLOGY

Dymind designs, manufactures and sells a range of auto hematology analyzers and home ventilator. The company also off... read more Featured Products: More products

Download Mobile App





Dymind Introduces New High-End Hematology Analyzer with Innovative Functions

By LabMedica International staff writers
Posted on 06 Feb 2024
Print article
Image: The new high-end DH-800 hematology analyzer showcased at Medlab Middle East 2024 (Photo courtesy of Dymind)
Image: The new high-end DH-800 hematology analyzer showcased at Medlab Middle East 2024 (Photo courtesy of Dymind)

Dymind Biotechnology (Shenzhen, China) is introducing its breakthroughs in medical solutions for hematology, coagulation, POCT, immunology, and veterinary at Medlab Middle East 2024, including its new high-end hematology analyzer DH-800 with and innovative functions.

Leveraging cutting-edge laser scattering fluorescent technology, intelligent warm bath technology, and advanced AI cube technology, DH-800 revolutionizes WBC/RBC/PLT detection. In addition to offering powerful detection for abnormal WBC/RBC/PLT, it also provides unprecedented automation for daily operation and maintenance. Featuring an enhanced automatic detection system for capillary blood, it offers various and flexible sampling modes. Other features include a 15.5-inch intuitive touchscreen, rotatable barcode scanning, bionic swirl mixing, closed puncture sampling, and 3D fluorescent analysis.

Dymind is also highlighting the CA1200 fully automated coagulation analyzer which integrates optical clotting and magnetic bead clotting methods for reliable results. The CA1200 features an adjustable touchscreen and interior lighting to maximize convenience along with an intelligent design to optimize workflow. At Medlab Middle East 2024, Dymind is also showcasing the DH20 3-part auto hematology analyzer. Compact and user-friendly, the DH20 can measure more clinical parameters using only 9ul sample volume and comes with an optional RF card and barcode function.

Related Links:
Dymind Biotechnology

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.